Pheochromocytomas with Aggressive Histopathological Features Have Reduced Apelin and Increased VEGF Expression: Diagnostic and Prognostic Implications.
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Konya City Hospital, University of Health Sciences, Konya 42020, Turkey.
- 2Department of Pathology, Konya City Hospital, Konya 42020, Turkey.
- 3Department of Pathology, Konya City Hospital, University of Health Sciences, Konya 42020, Turkey.
Abstract
Background: Pheochromocytoma is a highly vascular neuroendocrine tumor with variable biological behavior. Reliable biomarkers reflecting tumor aggressiveness remain limited. This study evaluated apelin and vascular endothelial growth factor (VEGF) expression in pheochromocytoma and their associations with histopathological prognostic parameters. Methods: This retrospective single-center study included 20 pheochromocytoma patients and 18 normal adrenal medulla controls. Apelin and VEGF expression were evaluated immunohistochemically using the immunoreactivity score (IRS). Associations between IRS values and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS), Grading System for Adrenal Pheochromocytoma and Paraganglioma (GAPP) score, Ki-67 index, tumor size, clinicopathological characteristics, and individual PASS components were analyzed. Results: Apelin IRS was significantly lower in pheochromocytoma than in normal adrenal medulla (median 0 vs. 4, p = 0.001), whereas VEGF IRS was significantly higher (median 6 vs. 2, p < 0.001). Tumors with PASS ≥ 4 had significantly lower apelin IRS than those with PASS < 4 (p = 0.001). Apelin IRS was inversely correlated with PASS (r = -0.874, p < 0.001), GAPP score (r = -0.618, p = 0.004), and Ki-67 (r = -0.560, p = 0.010). Lower apelin expression was also associated with diffuse growth pattern, central/confluent necrosis, and tumor cell spindling. VEGF IRS showed no significant association with PASS, GAPP score, Ki-67, tumor size, or individual PASS components. Conclusions: Reduced apelin immunoreactivity was associated with unfavorable histopathological features in pheochromocytoma, whereas increased VEGF immunoreactivity was not associated with the evaluated histopathological risk parameters. These exploratory findings suggest that apelin may be a candidate tissue marker; however, its clinical and prognostic relevance requires further investigation in larger multicenter studies.
Related
- Clinical and histopathological patterns of American cutaneous leishmaniasis: diagnostic and therapeutic implications for targeted therapy
- PD-L1 Expression and Clinicopathologic Associations in Mediastinal Aggressive Large B-Cell Lymphomas: A Retrospective Single-Center Study
- From Spiradenocarcinoma to Spiradenoma: A Case of Histopathological Diagnostic Reclassification
- Histopathological Remodeling and Reduced Hypoxia-Related Marker Expression Following Marsupialization of Ameloblastoma: A Paired Analysis
- Orbital involvement by spindle cell squamous cell carcinoma: a case report of a rare and aggressive tumor with diagnostic challenges
BibTeX
@article{burgucu2026pheochromocytomas,
title = {{Pheochromocytomas with Aggressive Histopathological Features Have Reduced Apelin and Increased VEGF Expression: Diagnostic and Prognostic Implications.}},
author = {Hatice Çalışkan Burgucu and Tuğba Günler and Ethem Ömeroğlu and Yaşar Ünlü and Oğuzhan Aksu},
journal = {Pathophysiology : the official journal of the International Society for Pathophysiology},
year = {2026},
month = sep,
doi = {10.3390/pathophysiology33040072},
url = {https://europepmc.org/article/MED/42924823},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pheochromocytomas with Aggressive Histopathological Features Have Reduced Apelin and Increased VEGF Expression: Diagnostic and Prognostic Implications.
AU - Hatice Çalışkan Burgucu
AU - Tuğba Günler
AU - Ethem Ömeroğlu
AU - Yaşar Ünlü
AU - Oğuzhan Aksu
PY - 2026
DA - 2026/09/24
JO - Pathophysiology : the official journal of the International Society for Pathophysiology
DO - 10.3390/pathophysiology33040072
UR - https://europepmc.org/article/MED/42924823
AB - Background: Pheochromocytoma is a highly vascular neuroendocrine tumor with variable biological behavior. Reliable biomarkers reflecting tumor aggressiveness remain limited. This study evaluated apelin and vascular endothelial growth factor (VEGF) expression in pheochromocytoma and their associations with histopathological prognostic parameters. Methods: This retrospective single-center study included 20 pheochromocytoma patients and 18 normal adrenal medulla controls. Apelin and VEGF expression were evaluated immunohistochemically using the immunoreactivity score (IRS). Associations between IRS values and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS), Grading System for Adrenal Pheochromocytoma and Paraganglioma (GAPP) score, Ki-67 index, tumor size, clinicopathological characteristics, and individual PASS components were analyzed. Results: Apelin IRS was significantly lower in pheochromocytoma than in normal adrenal medulla (median 0 vs. 4, p = 0.001), whereas VEGF IRS was significantly higher (median 6 vs. 2, p < 0.001). Tumors with PASS ≥ 4 had significantly lower apelin IRS than those with PASS < 4 (p = 0.001). Apelin IRS was inversely correlated with PASS (r = -0.874, p < 0.001), GAPP score (r = -0.618, p = 0.004), and Ki-67 (r = -0.560, p = 0.010). Lower apelin expression was also associated with diffuse growth pattern, central/confluent necrosis, and tumor cell spindling. VEGF IRS showed no significant association with PASS, GAPP score, Ki-67, tumor size, or individual PASS components. Conclusions: Reduced apelin immunoreactivity was associated with unfavorable histopathological features in pheochromocytoma, whereas increased VEGF immunoreactivity was not associated with the evaluated histopathological risk parameters. These exploratory findings suggest that apelin may be a candidate tissue marker; however, its clinical and prognostic relevance requires further investigation in larger multicenter studies.
SN - 0928-4680
SN - 1873-149X
ER -